invivo Mab anti-mouse PD-1 (CD279)

貨號:

BE0273

品牌:

Bioxcell

規格:

mg

概述

別名:

InVivoMab anti-mouse PD-1 (CD279)

克隆類(lèi)型:

Monoclonal Antibodies

詳述

抗體應用:

未定義

InVivoMab Antibodies來(lái)源：

20多年來(lái)，科學(xué)家一直相信bioxcell是體內功能級抗體的來(lái)源。我們牢記這一責任，始終致力于一個(gè)目標：生產(chǎn)高質(zhì)量、價(jià)值高的抗體。我們對科學(xué)家的堅定承諾激勵我們創(chuàng )造和優(yōu)化一種專(zhuān)利的體內抗體制造方法，具有顯著(zhù)的優(yōu)勢，直接使我們的客戶(hù)受益。? ? ? ? ? ? ? ? ?

Bio X Cell產(chǎn)品特點(diǎn)：

我們優(yōu)化的專(zhuān)利抗體制造方法確保超純抗體溶液不添加蛋白質(zhì)或化學(xué)物質(zhì)。使用SDS-PAGE對每個(gè)批次的純度進(jìn)行QC測試。

超低內毒素水平。我們的InVivoMAb產(chǎn)品≤2EU/mg，InVivoPlus產(chǎn)品≤1EU/mg。如果需要低于1EU/mg的內毒素水平，請聯(lián)系我們的技術(shù)支持以獲取詳細信息。

貨號	名稱(chēng)	?	克隆	反應性	抗原	宿主	同型	免疫原
BE0273-100MG	InVivoMab anti-mouse PD-1 (CD279)	?	29F.1A12	mouse	PD-1 (CD279)	rat	IgG2a, κ	Recombinant PD-1-Ig fusion protein
BE0273-1MG	InVivoMab anti-mouse PD-1 (CD279)	?	29F.1A12	mouse	PD-1 (CD279)	rat	IgG2a, κ	Recombinant PD-1-Ig fusion protein
BE0273-5MG	InVivoMab anti-mouse PD-1 (CD279)	?	29F.1A12	mouse	PD-1 (CD279)	rat	IgG2a, κ	Recombinant PD-1-Ig fusion protein
BE0273-25MG	InVivoMab anti-mouse PD-1 (CD279)	?	29F.1A12	mouse	PD-1 (CD279)	rat	IgG2a, κ	Recombinant PD-1-Ig fusion protein
BE0273-50MG	InVivoMab anti-mouse PD-1 (CD279)	?	29F.1A12	mouse	PD-1 (CD279)	rat	IgG2a, κ	Recombinant PD-1-Ig fusion protein
BE0274-100MG	InVivoMab anti-mouse TIGIT	?	1G9	mouse	TIGIT	mouse	IgG1, κ	Mouse TIGIT
BE0274-1MG	InVivoMab anti-mouse TIGIT	?	1G9	mouse	TIGIT	mouse	IgG1, κ	Mouse TIGIT
BE0274-5MG	InVivoMab anti-mouse TIGIT	?	1G9	mouse	TIGIT	mouse	IgG1, κ	Mouse TIGIT
BE0274-25MG	InVivoMab anti-mouse TIGIT	?	1G9	mouse	TIGIT	mouse	IgG1, κ	Mouse TIGIT
BE0274-50MG	InVivoMab anti-mouse TIGIT	?	1G9	mouse	TIGIT	mouse	IgG1, κ	Mouse TIGIT
BE0275-100MG	InVivoMab anti-mouse TIM-3 (CD366)	?	B8.2C12	mouse	TIM-3 (CD366)	rat	IgG1, κ	Mouse Tim-3 protein/Freund adjuvant
BE0275-1MG	InVivoMab anti-mouse TIM-3 (CD366)	?	B8.2C12	mouse	TIM-3 (CD366)	rat	IgG1, κ	Mouse Tim-3 protein/Freund adjuvant
BE0275-5MG	InVivoMab anti-mouse TIM-3 (CD366)	?	B8.2C12	mouse	TIM-3 (CD366)	rat	IgG1, κ	Mouse Tim-3 protein/Freund adjuvant
BE0275-25MG	InVivoMab anti-mouse TIM-3 (CD366)	?	B8.2C12	mouse	TIM-3 (CD366)	rat	IgG1, κ	Mouse Tim-3 protein/Freund adjuvant
BE0275-50MG	InVivoMab anti-mouse TIM-3 (CD366)	?	B8.2C12	mouse	TIM-3 (CD366)	rat	IgG1, κ	Mouse Tim-3 protein/Freund adjuvant
BE0276-100MG	InVivoMab anti-human/monkey CD20	?	2H7	human/monkey	CD20	mouse	IgG2b, κ	Human tonsillar B cells
BE0276-1MG	InVivoMab anti-human/monkey CD20	?	2H7	human/monkey	CD20	mouse	IgG2b, κ	Human tonsillar B cells
BE0276-5MG	InVivoMab anti-human/monkey CD20	?	2H7	human/monkey	CD20	mouse	IgG2b, κ	Human tonsillar B cells
BE0276-25MG	InVivoMab anti-human/monkey CD20	?	2H7	human/monkey	CD20	mouse	IgG2b, κ	Human tonsillar B cells
BE0276-50MG	InVivoMab anti-human/monkey CD20	?	2H7	human/monkey	CD20	mouse	IgG2b, κ	Human tonsillar B cells
BE0277-100MG	InVivoMab anti-human/rat HER2 (neu)	?	7.16.4	human/rat	HER2 (neu)	mouse?	IgG2a	neu-transfected NIH 3T3 cells
BE0277-1MG	InVivoMab anti-human/rat HER2 (neu)	?	7.16.4	human/rat	HER2 (neu)	mouse?	IgG2a	neu-transfected NIH 3T3 cells
BE0277-5MG	InVivoMab anti-human/rat HER2 (neu)	?	7.16.4	human/rat	HER2 (neu)	mouse?	IgG2a	neu-transfected NIH 3T3 cells
BE0277-25MG	InVivoMab anti-human/rat HER2 (neu)	?	7.16.4	human/rat	HER2 (neu)	mouse?	IgG2a	neu-transfected NIH 3T3 cells
BE0277-50MG	InVivoMab anti-human/rat HER2 (neu)	?	7.16.4	human/rat	HER2 (neu)	mouse?	IgG2a	neu-transfected NIH 3T3 cells
BE0278-100MG	InVivoMab anti-human EGFR	?	225 (HB-8508)	human	EGFR	mouse?	IgG1	Purified EGFR from A431 cells
BE0278-1MG	InVivoMab anti-human EGFR	?	225 (HB-8508)	human	EGFR	mouse?	IgG1	Purified EGFR from A431 cells
BE0278-5MG	InVivoMab anti-human EGFR	?	225 (HB-8508)	human	EGFR	mouse?	IgG1	Purified EGFR from A431 cells
BE0278-25MG	InVivoMab anti-human EGFR	?	225 (HB-8508)	human	EGFR	mouse?	IgG1	Purified EGFR from A431 cells
BE0278-50MG	InVivoMab anti-human EGFR	?	225 (HB-8508)	human	EGFR	mouse?	IgG1	Purified EGFR from A431 cells
BE0279-100MG	InVivoMab anti-human EGFR	?	528 (HB-8509)	human	EGFR	mouse?	IgG2a	Purified EGFR from A431 cells
BE0279-1MG	InVivoMab anti-human EGFR	?	528 (HB-8509)	human	EGFR	mouse?	IgG2a	Purified EGFR from A431 cells
BE0279-5MG	InVivoMab anti-human EGFR	?	528 (HB-8509)	human	EGFR	mouse?	IgG2a	Purified EGFR from A431 cells
BE0279-25MG	InVivoMab anti-human EGFR	?	528 (HB-8509)	human	EGFR	mouse?	IgG2a	Purified EGFR from A431 cells
BE0279-50MG	InVivoMab anti-human EGFR	?	528 (HB-8509)	human	EGFR	mouse?	IgG2a	Purified EGFR from A431 cells
BE0280-100MG	InVivoMab anti-mouse c-Kit (CD117)	?	2B8	mouse	c-Kit (CD117)	rat	IgG2b, κ	Mouse bone marrow mast cells
BE0280-1MG	InVivoMab anti-mouse c-Kit (CD117)	?	2B8	mouse	c-Kit (CD117)	rat	IgG2b, κ	Mouse bone marrow mast cells
BE0280-5MG	InVivoMab anti-mouse c-Kit (CD117)	?	2B8	mouse	c-Kit (CD117)	rat	IgG2b, κ	Mouse bone marrow mast cells
BE0280-25MG	InVivoMab anti-mouse c-Kit (CD117)	?	2B8	mouse	c-Kit (CD117)	rat	IgG2b, κ	Mouse bone marrow mast cells
BE0280-50MG	InVivoMab anti-mouse c-Kit (CD117)	?	2B8	mouse	c-Kit (CD117)	rat	IgG2b, κ	Mouse bone marrow mast cells
BE0281-100MG	InVivoMab anti-human CD19	?	4G7	human	CD19	mouse?	IgG1	Human chronic lymphocytic leukemia (CLL) cells
BE0281-1MG	InVivoMab anti-human CD19	?	4G7	human	CD19	mouse?	IgG1	Human chronic lymphocytic leukemia (CLL) cells
BE0281-5MG	InVivoMab anti-human CD19	?	4G7	human	CD19	mouse?	IgG1	Human chronic lymphocytic leukemia (CLL) cells
BE0281-25MG	InVivoMab anti-human CD19	?	4G7	human	CD19	mouse?	IgG1	Human chronic lymphocytic leukemia (CLL) cells
BE0281-50MG	InVivoMab anti-human CD19	?	4G7	human	CD19	mouse?	IgG1	Human chronic lymphocytic leukemia (CLL) cells
BE0282-100MG	InVivoMab anti-mouse IL-3	?	MP2-8F8	mouse	IL-3	rat?	IgG1	COS-expressed, recombinant mouse IL-3
BE0282-1MG	InVivoMab anti-mouse IL-3	?	MP2-8F8	mouse	IL-3	rat?	IgG1	COS-expressed, recombinant mouse IL-3
BE0282-5MG	InVivoMab anti-mouse IL-3	?	MP2-8F8	mouse	IL-3	rat?	IgG1	COS-expressed, recombinant mouse IL-3
BE0282-25MG	InVivoMab anti-mouse IL-3	?	MP2-8F8	mouse	IL-3	rat?	IgG1	COS-expressed, recombinant mouse IL-3
BE0282-50MG	InVivoMab anti-mouse IL-3	?	MP2-8F8	mouse	IL-3	rat?	IgG1	COS-expressed, recombinant mouse IL-3
BE0283-100MG	InVivoMab anti-human/mouse/rat CD47	?	MIAP410	human/mouse/rat?	CD47	mouse	IgG1, κ	purified human placental CD47
BE0283-1MG	InVivoMab anti-human/mouse/rat CD47	?	MIAP410	human/mouse/rat?	CD47	mouse	IgG1, κ	purified human placental CD47
BE0283-5MG	InVivoMab anti-human/mouse/rat CD47	?	MIAP410	human/mouse/rat?	CD47	mouse	IgG1, κ	purified human placental CD47
BE0283-25MG	InVivoMab anti-human/mouse/rat CD47	?	MIAP410	human/mouse/rat?	CD47	mouse	IgG1, κ	purified human placental CD47
BE0283-50MG	InVivoMab anti-human/mouse/rat CD47	?	MIAP410	human/mouse/rat?	CD47	mouse	IgG1, κ	purified human placental CD47
BE0285-100MG	InVivoMab anti-human PD-L1 (B7-H1)	?	29E.2A3	human	PD-L1 (B7-H1)	mouse	IgG2b, κ	Full length human PD-L1
BE0285-1MG	InVivoMab anti-human PD-L1 (B7-H1)	?	29E.2A3	human	PD-L1 (B7-H1)	mouse	IgG2b, κ	Full length human PD-L1
BE0285-5MG	InVivoMab anti-human PD-L1 (B7-H1)	?	29E.2A3	human	PD-L1 (B7-H1)	mouse	IgG2b, κ	Full length human PD-L1
BE0285-25MG	InVivoMab anti-human PD-L1 (B7-H1)	?	29E.2A3	human	PD-L1 (B7-H1)	mouse	IgG2b, κ	Full length human PD-L1
BE0285-50MG	InVivoMab anti-human PD-L1 (B7-H1)	?	29E.2A3	human	PD-L1 (B7-H1)	mouse	IgG2b, κ	Full length human PD-L1
BE0287-100MG	InVivoMab anti-mouse IFNγRα (CD119)	?	2E2	mouse	IFNγRα (CD119)	Armenian hamster	IgG	Purified soluble recombinant mouse IFNγRα chain
BE0287-1MG	InVivoMab anti-mouse IFNγRα (CD119)	?	2E2	mouse	IFNγRα (CD119)	Armenian hamster	IgG	Purified soluble recombinant mouse IFNγRα chain
BE0287-5MG	InVivoMab anti-mouse IFNγRα (CD119)	?	2E2	mouse	IFNγRα (CD119)	Armenian hamster	IgG	Purified soluble recombinant mouse IFNγRα chain
BE0287-25MG	InVivoMab anti-mouse IFNγRα (CD119)	?	2E2	mouse	IFNγRα (CD119)	Armenian hamster	IgG	Purified soluble recombinant mouse IFNγRα chain
BE0287-50MG	InVivoMab anti-mouse IFNγRα (CD119)	?	2E2	mouse	IFNγRα (CD119)	Armenian hamster	IgG	Purified soluble recombinant mouse IFNγRα chain
BE0288-100MG	InVivoMab anti-human CD4	?	RPA-T4	human	CD4	mouse	IgG1, κ	?
BE0288-1MG	InVivoMab anti-human CD4	?	RPA-T4	human	CD4	mouse	IgG1, κ	?
BE0288-5MG	InVivoMab anti-human CD4	?	RPA-T4	human	CD4	mouse	IgG1, κ	?
BE0288-25MG	InVivoMab anti-human CD4	?	RPA-T4	human	CD4	mouse	IgG1, κ	?
BE0288-50MG	InVivoMab anti-human CD4	?	RPA-T4	human	CD4	mouse	IgG1, κ	?
BE0289-100MG	InVivoMAb anti-mouse TIM-1 (CD365)	?	3B3	mouse	TIM-1 (CD365)	rat	IgG2a, κ	Mouse TIM-1 (signal and IgV domains) mouse IgG2a Fc fusion protein
BE0289-1MG	InVivoMAb anti-mouse TIM-1 (CD365)	?	3B3	mouse	TIM-1 (CD365)	rat	IgG2a, κ	Mouse TIM-1 (signal and IgV domains) mouse IgG2a Fc fusion protein
BE0289-5MG	InVivoMAb anti-mouse TIM-1 (CD365)	?	3B3	mouse	TIM-1 (CD365)	rat	IgG2a, κ	Mouse TIM-1 (signal and IgV domains) mouse IgG2a Fc fusion protein
BE0289-25MG	InVivoMAb anti-mouse TIM-1 (CD365)	?	3B3	mouse	TIM-1 (CD365)	rat	IgG2a, κ	Mouse TIM-1 (signal and IgV domains) mouse IgG2a Fc fusion protein
BE0289-50MG	InVivoMAb anti-mouse TIM-1 (CD365)	?	3B3	mouse	TIM-1 (CD365)	rat	IgG2a, κ	Mouse TIM-1 (signal and IgV domains) mouse IgG2a Fc fusion protein
BE0291-100MG	InVivoMAb anti-human/monkey CD28	?	CD28.2	human/monkey	CD28	mouse	IgG1, κ	Human CD28 transfected cell line
BE0291-1MG	InVivoMAb anti-human/monkey CD28	?	CD28.2	human/monkey	CD28	mouse	IgG1, κ	Human CD28 transfected cell line
BE0291-5MG	InVivoMAb anti-human/monkey CD28	?	CD28.2	human/monkey	CD28	mouse	IgG1, κ	Human CD28 transfected cell line
BE0291-25MG	InVivoMAb anti-human/monkey CD28	?	CD28.2	human/monkey	CD28	mouse	IgG1, κ	Human CD28 transfected cell line
BE0291-50MG	InVivoMAb anti-human/monkey CD28	?	CD28.2	human/monkey	CD28	mouse	IgG1, κ	Human CD28 transfected cell line
BE0292-100MG	InVivoMAb anti-human/monkey CD40L (CD154)	?	5C8	human/monkey	CD40L (CD154)	mouse?	IgG2a	Human D1.1 T cell line
BE0292-1MG	InVivoMAb anti-human/monkey CD40L (CD154)	?	5C8	human/monkey	CD40L (CD154)	mouse?	IgG2a	Human D1.1 T cell line
BE0292-5MG	InVivoMAb anti-human/monkey CD40L (CD154)	?	5C8	human/monkey	CD40L (CD154)	mouse?	IgG2a	Human D1.1 T cell line
BE0292-25MG	InVivoMAb anti-human/monkey CD40L (CD154)	?	5C8	human/monkey	CD40L (CD154)	mouse?	IgG2a	Human D1.1 T cell line
BE0292-50MG	InVivoMAb anti-human/monkey CD40L (CD154)	?	5C8	human/monkey	CD40L (CD154)	mouse?	IgG2a	Human D1.1 T cell line
BE0294-100MG	InVivoMAb anti-mouse E-selectin (CD62E)	?	9A9	mouse	E-selectin (CD62E)	rat?	IgG2b	COS-expressed, recombinant mouse E-selectin
BE0294-1MG	InVivoMAb anti-mouse E-selectin (CD62E)	?	9A9	mouse	E-selectin (CD62E)	rat?	IgG2b	COS-expressed, recombinant mouse E-selectin
BE0294-5MG	InVivoMAb anti-mouse E-selectin (CD62E)	?	9A9	mouse	E-selectin (CD62E)	rat?	IgG2b	COS-expressed, recombinant mouse E-selectin
BE0294-25MG	InVivoMAb anti-mouse E-selectin (CD62E)	?	9A9	mouse	E-selectin (CD62E)	rat?	IgG2b	COS-expressed, recombinant mouse E-selectin
BE0294-50MG	InVivoMAb anti-mouse E-selectin (CD62E)	?	9A9	mouse	E-selectin (CD62E)	rat?	IgG2b	COS-expressed, recombinant mouse E-selectin
BE0296-100MG	InVivoMAb anti-mouse 4-1BB (CD137)	?	17B5	mouse	4-1BB (CD137)	Syrian hamster	IgG	?
BE0296-1MG	InVivoMAb anti-mouse 4-1BB (CD137)	?	17B5	mouse	4-1BB (CD137)	Syrian hamster	IgG	?
BE0296-5MG	InVivoMAb anti-mouse 4-1BB (CD137)	?	17B5	mouse	4-1BB (CD137)	Syrian hamster	IgG	?
BE0296-25MG	InVivoMAb anti-mouse 4-1BB (CD137)	?	17B5	mouse	4-1BB (CD137)	Syrian hamster	IgG	?
BE0296-50MG	InVivoMAb anti-mouse 4-1BB (CD137)	?	17B5	mouse	4-1BB (CD137)	Syrian hamster	IgG	?
BE0298-100MG	InVivoMAb anti-mouse CD122 (IL-2Rβ)	?	TM-Beta 1	mouse	CD122 (IL-2Rβ)	rat	IgG2b, κ	Mouse IL-2Rβ transfected cell line (TART-mβ cells)
BE0298-1MG	InVivoMAb anti-mouse CD122 (IL-2Rβ)	?	TM-Beta 1	mouse	CD122 (IL-2Rβ)	rat	IgG2b, κ	Mouse IL-2Rβ transfected cell line (TART-mβ cells)
BE0298-5MG	InVivoMAb anti-mouse CD122 (IL-2Rβ)	?	TM-Beta 1	mouse	CD122 (IL-2Rβ)	rat	IgG2b, κ	Mouse IL-2Rβ transfected cell line (TART-mβ cells)
BE0298-25MG	InVivoMAb anti-mouse CD122 (IL-2Rβ)	?	TM-Beta 1	mouse	CD122 (IL-2Rβ)	rat	IgG2b, κ	Mouse IL-2Rβ transfected cell line (TART-mβ cells)
BE0298-50MG	InVivoMAb anti-mouse CD122 (IL-2Rβ)	?	TM-Beta 1	mouse	CD122 (IL-2Rβ)	rat	IgG2b, κ	Mouse IL-2Rβ transfected cell line (TART-mβ cells)
BE0299-100MG	InVivoMAb anti-mouse CD200 (OX2)	?	OX-90	mouse	CD200 (OX2)	rat	IgG2a, κ	Fusion protein consisting of mouse CD200 (extracellular region) and rat CD4 (domains 3 and 4)
BE0299-1MG	InVivoMAb anti-mouse CD200 (OX2)	?	OX-90	mouse	CD200 (OX2)	rat	IgG2a, κ	Fusion protein consisting of mouse CD200 (extracellular region) and rat CD4 (domains 3 and 4)
BE0299-5MG	InVivoMAb anti-mouse CD200 (OX2)	?	OX-90	mouse	CD200 (OX2)	rat	IgG2a, κ	Fusion protein consisting of mouse CD200 (extracellular region) and rat CD4 (domains 3 and 4)
BE0299-25MG	InVivoMAb anti-mouse CD200 (OX2)	?	OX-90	mouse	CD200 (OX2)	rat	IgG2a, κ	Fusion protein consisting of mouse CD200 (extracellular region) and rat CD4 (domains 3 and 4)
BE0299-50MG	InVivoMAb anti-mouse CD200 (OX2)	?	OX-90	mouse	CD200 (OX2)	rat	IgG2a, κ	Fusion protein consisting of mouse CD200 (extracellular region) and rat CD4 (domains 3 and 4)

濃度：2-10 mg/m

l

儲存與安全

儲存:

4℃

關(guān)于我們

Wolcavi Biotech致力于干細胞免疫治療、分子生物學(xué) 、免疫學(xué)、體外診斷等相關(guān)領(lǐng)域的實(shí)驗需求產(chǎn)品開(kāi)發(fā)和銷(xiāo)售。主要產(chǎn)品有抗原抗體|無(wú)血清培養基|細胞培養耗材并代理銷(xiāo)售Abcam、Invitrogen(Gibco)、Roche、Sigma、R&D、Meridian等二十多家國外知名品牌。

聯(lián)系我們

北京市通州區金橋科技園景盛南二街12號納特園區
Phone: +86 010 8646 3560
Email: info@wolcavi.com

新聞

標簽

?
?
?
?
?

?
010-5944 6861

亚洲va在线va天堂va偷拍|99久久久久无码国产精品|一本久久a久久免费精品网站|午夜精品久久久久久毛片777|国产95在线 | 欧美|欧美一区二区三区高清在线|亚欧无码视频一区二区三区

亚洲va在线va天堂va偷拍|99久久久久无码国产精品|一本久久a久久免费精品网站|午夜精品久久久久久毛片777|国产95在线 | 欧美|欧美一区二区三区高清在线|亚欧无码视频一区二区三区

invivo Mab anti-mouse PD-1 (CD279)